The NINDS Office of Translational Research (OTR) manages a large portfolio of grant-funded projects, and R&D resources to facilitate the preclinical discovery and development of therapeutics and devices for neurological disorders. In addition to therapeutics development, OTR’s mission is to support research infrastructure for therapeutic development including drug target validation, the development of assays, and animal disease models and pre-IND and pre-IDE enabling studies.
Program Director, Cooperative Program in Translational Research –
OTR is seeking an entrepreneurial senior-level science executive for the position of Program Director, Cooperative Program in Translational Research to design and administer milestone-based grants. These grants currently provide up to $1 million per year in direct costs for 5 years in funding, to academic and industry researchers, to support the development of therapeutics and devices for the treatment of neurological diseases to the IND/IDE stage. The Program Director will oversee a team and be responsible for all aspects of the program. They will also have the opportunity to provide leadership to the neuroscience community on productive preclinical translational research strategies for neurological disorders. The candidate must have a MD or PhD degree in neuroscience, neurology, psychiatry, pharmacology, or one of the drug development sciences such as medicinal chemistry, DMPK, or toxicology. The candidate must also have 7+ plus years of experience developing therapeutics or devices for the treatment of neurological, neuroinflammatory, or psychiatric diseases.
Program Director, Preclinical Pharmacology – The OTR is seeking an innovative senior scientist for the position of Program Director, Preclinical Pharmacology to manage all aspects of OTR’s Preclinical Pharmacology Program, including the Anticonvulsant Screening Program (ASP). The Preclinical Pharmacology Program includes: implementing best practices in animal model development and
in vivo screening strategies; managing all aspects of the ASP, which provides screening services to characterize and profile novel anti-epileptic agents; and implementing an expanding portfolio of
in vivo model programs. The candidate must have a PhD in pharmacology and background in neuroscience or neurology research; 7+ years industry experience conducting preclinical pharmacology and drug discovery screening studies; accomplishments using pharmacodynamics, drug metabolism, pharmacokinetics and innovative experimental design in animal model studies; and the ability to manage large animal disease models and compound screening contracts.
To be considered for this exciting and impactful role, please contact Dr. Eric Nelson (This email address is being protected from spambots. You need JavaScript enabled to view it.) in OTR for more information.
Office of Translational Research
6001 Executive Boulevard
Bethesda, Maryland 20892